Cite
HARVARD Citation
Groeneweg, S. et al. (2019). Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial. Lancet. 7 (9), pp. 695-706. [Online].